The natural history and longitudinal outcomes of patients with mild-to-moderate ulcerative proctitis or ulcerative proctosigmoiditis: a single-center, retrospective study

Author:

Ye Kexin1,Jin Zhenhe1,Chen Qichen1,Cen Li1,Pan Jiaqi1,Zhou Tianyu1,Jiang Wenxi1,Liu Zhaoxue1,Luo Linwen1,Shen Zhe1

Affiliation:

1. First Affiliated Hospital Zhejiang University

Abstract

Abstract

Background Ulcerative proctitis (UP) and ulcerative proctosigmoiditis (UPS) are special forms of ulcerative colitis. The disease burdens of UP and UPS are increasing. However, the natural history and prognosis of patients with mild-to-moderate UP or UPS have been poorly studied. Aims The aim of this study is to evaluate the characteristics, short-term and long-term outcomes of patients with mild-to-moderate UP or UPS followed at a single center over a period of 3 years. Methods A retrospective study of patients with UP and UPS followed at a single center from 2021 to 2023 was performed. After scanning for inclusion and exclusion criteria, patient demographics and clinical data were collected. Disease severity was accessed by Myao endoscopy scores and ulcerative colitis endoscopic index of severity. Endoscopic improvement was defined as decreased scores at the last follow-up. Disease extension was defined as endoscopic evidence of a greater extent of disease at the last follow-up. Results A total of 414 patients were included for evaluation, of which 292 patients (70.53%) were at mild disease stage, and 122 patients (29.47%) had moderate diseases. At the last follow-up, 315 patients (76.09%) showed endoscopic improvement, and 247 patients (59.66%) showed endoscopic remission. An overall extension rate of 11.11% was observed at the last follow-up. Subgroup analysis revealed a better prognosis in younger patients. The disease extension rate was higher in moderate group and symptomatic patients. Conclusions Promising outcomes were observed in patients with mild-to-moderate ulcerative proctitis or ulcerative proctosigmoiditis. Disease severity and symptoms are correlated with the risk of extension.

Publisher

Springer Science and Business Media LLC

Reference16 articles.

1. Ulcerative colitis;Ordás I;Lancet Lond Engl,2012

2. C LB, S H, L P-B. Ulcerative colitis. Lancet Lond Engl [Internet]. 2023 [cited 2024 Feb 16];402. Available from: https://pubmed.ncbi.nlm.nih.gov/37573077/

3. Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort;Dubois E;United Eur Gastroenterol J,2020

4. Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository;Kato S;Digestion,2018

5. Mr L, Sl K, Be H, Cj van der W. Drug therapies for ulcerative proctitis: systematic review and meta-analysis. Inflamm Bowel Dis [Internet]. 2014 [cited 2024 Feb 28];20. Available from: https://pubmed.ncbi.nlm.nih.gov/25072502/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3